publication venue for Selecting treatment options for TKI-resistant chronic myeloid leukemia. 12. 2014 Impact of CINV. 9. 2011 T-cell lymphoma: Where we are going. 8. 2010 Phase III randomized study of R-CHOP vs dose-adjusted EPOCH-R with molecular profiling in untreated de novo diffuse large B-cell lymphoma. 4. 2006
